Stevens-Johnson Syndrome Treatments
Find Stevens-Johnson Syndrome Treatments
MethylPREDNISolone Acetate
What is Depo-Medrol (MethylPREDNISolone Acetate)?
Approved To Treat
Top Global Experts
Related Clinical Trials
Summary: The objectives of this study are to identify an optimal transcutaneous auricular vagus nerve stimulation (taVNS) dosing regimen for pain relief and anti-inflammatory effects in Veterans with knee osteoarthritis (OA), compared to corticosteroid injection (CSI), and lay the groundwork for future combinatorial therapies with cell-based approaches. The population for this study is Veterans with osteoa...
Summary: This study aims to analyze the efficacy and safety of different kinds of steroid injections for back pain, comparing different steroids, dosages, locations (epidural, facet joints, nerve blocks), and also the difference between injections with steroids and local anesthetics, to optimize this treatment that is currently not standardized. The investigators will compare retrospectively and prospectiv...
Summary: The objective of this phase 2 study is to investigate the efficacy of Dexamethasone sodium phosphate (DEX) plus Methylprednisolone acetate (MPA) in combination with plain bupivacaine (B) compared with Liposomal Bupivacaine (LB) in combination with plain bupivacaine on post-surgical pain control among patients undergoing unilateral total knee arthroplasty (TKA) to asses if perineural B-DEX-MPA will...
Related Latest Advances
Brand Information

NDC 0009-0274-01
(methylPREDNISolone acetate
injectable suspension, USP)
Rx only

Multidose Vial
(methylPREDNISolone
acetate injectable
suspension, USP)
as a Preservative

NDC 0009-0280-02
(methylPREDNISolone acetate
injectable suspension, USP)
(40 mg/mL)

(methylPREDNISolone acetate injectable suspension, USP)
(40 mg/mL)

NDC 0009-0306-02
(methylPREDNISolone acetate
injectable suspension, USP)
(80 mg/mL)

Multidose Vial
(methylPREDNISolone
acetate injectable
suspension, USP)
(80 mg/mL)
as a Preservative
